References
Rhodes A et al (2017) Surviving sepsis campaign:international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43:304–377
De Backer D, Aldecoa C, Njimi H, Vincent JL (2012) Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med 40:725–730
Myburgh JA, Higgins A, Jovanovska A et al (2008) A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34(12):2226–2234
Russell JA, Walley KR, Singer J et al (2008) Vasopressin versus nor- epinephrine infusion in patients with septic shock. N Engl J Med 358(9):877–887
Venkatesh B, Finfer S, Cohen J et al (2018) Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 378:797–808
Annane D, Renault A, Brun-Buisson C et al (2018) Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med 378:809–818
Maheshwari K, Nathanson BH, Munson SH et al (2018) The relationship between ICU hypotension and in-hospital mortality and morbidity in septic patients. Intensive Care Med 44:857–867
Asfar P, Meziani F, Hamel JF et al (2014) High versus low blood-pressure target in patients with septic shock. N Engl J Med 370(17):1583–1593
Maitland K, Kiguli S, Opoka RO et al (2011) Mortality after fluid bolus in African children with severe infection. N Engl J Med 364(26):2483–2495
De Oliveira FS, Freitas FG, Ferreira EM et al (2015) Positive fluid balance as a prognostic factor for mortality and acute kidney injury in severe sepsis and septic shock. J Crit Care 30(1):97–101
Gordon AC, Mason AJ, Thirunavukkarasu N et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316(5):509–518
Levy B, Fritz C, Tahon E et al (2018) Vasoplegia treatments: the past, the present, and the future. Crit Care 22:52
Belletti A, Musu M, Silvetti S et al (2015) Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials. PLoS One 10(11):e0142605
Khanna A, English SW, Wang XS et al (2017) Angiotensin II for the treatment of vasodilatory shock. N Engl J Med 377(5):419–430
Cohen J, Venkatesh B (2019) Adjunctive corticosteroid treatment in septic shock. Anesthesiology. https://doi.org/10.1097/aln.0000000000002604
Annane D, Cariou A, Maxime V et al (2010) Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 303:341–348
Tumlin JA, Murugan R, Deane AM et al (2018) Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II. Crit Care Med 46(6):949–957
Putzu A, Schorer R, Lopez-Delgado JC, Cassina T, Landoni G (2019) Blood purification and mortality in sepsis and septic shock: a systematic review and meta-analysis of randomized trials. Anesthesiology. https://doi.org/10.1097/aln.0000000000002820
Permpikul C, Tongyoo S, Viarasilpa T, Trainarongsakul T, Chakorn T, Udompanturak S (2019) Early use of norepinephrine in septic shock resuscitation (CENSER): a randomized trial. Am J Respir Crit Care Med 199:1097–1105
Vail E, Gershengorn HB, Hua M, Walkey AJ, Rubenfeld G, Wunsch H (2017) Association between US norepinephrine shortage and mortality among patients with septic shock. JAMA 317(14):1433–1442
Acknowledgements
Prof. Venkatesh is supported by an NHMRC-Medical Research Future Fund Practitioner Fellowship. This work was also supported by an NHMRC grant APP1161182.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors do not have any financial conflict of interest in association with this manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Venkatesh, B., Khanna, A.K. & Cohen, J. Less is more: catecholamine-sparing strategies in septic shock. Intensive Care Med 45, 1810–1812 (2019). https://doi.org/10.1007/s00134-019-05770-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-019-05770-3